Royal Bank Of Canada Emergent Bio Solutions Inc. Transaction History

Royal Bank Of Canada

$479 Billion
Q4 2024

A detailed history of Royal Bank Of Canada transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 1,042 shares of EBS stock, worth $5,960. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,042

Previous 1,836 43.25%

Holding current value

$5,960

Previous $15,000 40.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$7.72 - $11.97 $6,129 - $9,504	-794 Reduced 43.25%	1,042 $9,000
Q3 2024 Nov 14, 2024	SELL	$5.72 - $14.77 $10,370 - $26,778	-1,813 Reduced 49.68%	1,836 $15,000
Q2 2024 Aug 14, 2024	BUY	$1.86 - $6.98 $4,534 - $17,017	2,438 Added 201.32%	3,649 $24,000
Q1 2024 Nov 05, 2024	SELL	$1.5 - $3.41 $3,657 - $8,313	-2,438 Reduced 66.81%	1,211 $3,000
Q1 2024 May 15, 2024	SELL	$1.5 - $3.41 $35,692 - $81,140	-23,795 Reduced 95.16%	1,211 $3,000
Q4 2023 Feb 14, 2024	SELL	$1.82 - $3.16 $96,061 - $166,787	-52,781 Reduced 67.85%	25,006 $60,000
Q3 2023 Nov 14, 2023	SELL	$3.17 - $7.91 $119,090 - $297,162	-37,568 Reduced 32.57%	77,787 $264,000
Q2 2023 Aug 14, 2023	BUY	$7.35 - $13.21 $675,494 - $1.21 Million	91,904 Added 391.9%	115,355 $847,000
Q1 2023 May 15, 2023	BUY	$7.79 - $16.29 $25,317 - $52,942	3,250 Added 16.09%	23,451 $242,000
Q4 2022 Feb 14, 2023	BUY	$11.0 - $21.45 $196,317 - $382,818	17,847 Added 758.16%	20,201 $238,000
Q3 2022 Nov 14, 2022	BUY	$20.09 - $35.8 $12,817 - $22,840	638 Added 37.18%	2,354 $50,000
Q2 2022 Aug 15, 2022	SELL	$27.42 - $43.63 $85,714 - $136,387	-3,126 Reduced 64.56%	1,716 $54,000
Q1 2022 May 16, 2022	SELL	$36.48 - $52.22 $466,396 - $667,632	-12,785 Reduced 72.53%	4,842 $198,000
Q4 2021 Feb 14, 2022	SELL	$33.11 - $55.01 $12.6 Million - $20.9 Million	-379,190 Reduced 95.56%	17,627 $767,000
Q3 2021 Nov 15, 2021	BUY	$50.07 - $66.05 $1.92 Million - $2.53 Million	38,291 Added 10.68%	396,817 $19.9 Million
Q2 2021 Aug 16, 2021	BUY	$56.61 - $80.46 $20.3 Million - $28.8 Million	358,526 New	358,526 $22.6 Million

Others Institutions Holding EBS

# of Institutions

174

Shares Held

36.8M

Call Options Held

336K

Put Options Held

203K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $285M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Emergent Bio Solutions Inc. Transaction History